Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03432325 · ClinicalTrials.gov registry record · NA

Neural Enabled Prosthesis for Upper Limb Amputees

A NA study of Prosthesis User and Amputation Arm and Hand, Unilateral Right, sponsored by University of Arkansas, Fayetteville.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
2
Study locations

NCT03432325 is a NA study of Prosthesis User and Amputation Arm and Hand, Unilateral Right that is actively recruiting participants, run by University of Arkansas, Fayetteville. The registered enrollment target is 15 participants, below the 56-participant average among 12 other Prosthesis User trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03432325, a NA study of Prosthesis User and Amputation Arm and Hand, Unilateral Right, is actively recruiting participants, sponsored by University of Arkansas, Fayetteville.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
2
Study locations

Study Summary

This study is designed to evaluate the feasibility of The Adaptive Neural Systems Neural-Enabled Prosthetic Hand (ANS-NEPH) system.

Interventions

  • DEVICE Neural Enabled Prosthesis

Study Locations (2)

Arkansas

  • University of Arkansas - Fayetteville

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2017-12-14
Est. Completion 2025-12-31
Phase NA

What the Registry Record Tells You About NCT03432325

The ClinicalTrials.gov registry entry for NCT03432325 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 12 other Prosthesis User trials with a reported enrollment target (73% lower). The listed sponsor is University of Arkansas, Fayetteville, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Prosthesis User appearing as the primary indexed condition, and to 1 intervention - of which Neural Enabled Prosthesis is the first listed.

NCT03432325 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arkansas, Maryland.

Frequently Asked Questions

What is clinical trial NCT03432325 about?

NCT03432325 is a clinical study titled "Neural Enabled Prosthesis for Upper Limb Amputees". This study is designed to evaluate the feasibility of The Adaptive Neural Systems Neural-Enabled Prosthetic Hand (ANS-NEPH) system.

What is the current status of trial NCT03432325?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2017-12-14. Estimated completion is 2025-12-31.

What conditions does trial NCT03432325 study?

This clinical trial studies the following conditions: Prosthesis User, Amputation Arm and Hand, Unilateral Right, Amputation Arm and Hand, Unilateral Left.

What interventions are being tested in trial NCT03432325?

The interventions under investigation include: Neural Enabled Prosthesis (DEVICE).

Who is sponsoring clinical trial NCT03432325?

This trial is sponsored by University of Arkansas, Fayetteville, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03432325 being conducted?

This trial has 2 study locations across Arkansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prosthesis User

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.